Stock Research for LXRX


Featured Broker: Ally Invest

Get the due diligence for another stock.


LXRX Stock Chart & Research Data

The LXRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the LXRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


LXRX Due diligence Resources & Stock Charts

The LXRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View LXRX Detailed Price Forecast - CNN Money CNN View LXRX Detailed Summary - Google Finance
Yahoo View LXRX Detailed Summary - Yahoo! Finance Zacks View LXRX Stock Research & Analysis -

Stock Analysis

TradeIdeas View LXRX Trends & Analysis - Trade-Ideas Barrons View LXRX Major Holders - Barrons
NASDAQ View LXRX Call Transcripts - NASDAQ Seeking View LXRX Breaking News & Analysis - Seeking Alpha
Spotlight View LXRX Annual Report - OTC Report View LXRX OTC Short Report -
TradeKing View LXRX Fundamentals - TradeKing Charts View LXRX SEC Filings - Bar Chart
WSJ View Historical Prices for LXRX - The WSJ Morningstar View Performance/Total Return for LXRX - Morningstar
MarketWatch View the Analyst Estimates for LXRX - MarketWatch CNBC View the Earnings History for LXRX - CNBC
StockMarketWatch View the LXRX Earnings - StockMarketWatch MacroAxis View LXRX Buy or Sell Recommendations - MacroAxis
Bullish View the LXRX Bullish Patterns - American Bulls Short Pains View LXRX Short Pain Metrics -

Social Media Mentions

StockTwits View LXRX Stock Mentions - StockTwits PennyStocks View LXRX Stock Mentions - PennyStockTweets
Twitter View LXRX Stock Mentions - Twitter Invest Hub View LXRX Investment Forum News - Investor Hub
Yahoo View LXRX Stock Mentions - Yahoo! Message Board Seeking Alpha View LXRX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for LXRX - Insider Cow View Insider Transactions for LXRX - Insider Cow
CNBC View LXRX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for LXRX - OTC Markets
Yahoo View Insider Transactions for LXRX - Yahoo! Finance NASDAQ View Institutional Holdings for LXRX - NASDAQ

Stock Charts

FinViz View LXRX Stock Insight & Charts - StockCharts View LXRX Investment Charts -
BarChart View LXRX Stock Overview & Charts - BarChart Trading View View LXRX User Generated Charts - Trading View

Latest Financial News for LXRX

Tyme Technologies, Inc. (TYME), Vale S.A. (VALE) & Lexicon Pharmaceuticals, Inc. (LXRX) Bronstein, Gewirtz & Grossman, LLC Class Action Update
Posted on Friday February 22, 2019

NEW YORK, NY / ACCESSWIRE / February 22, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can ...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – LXRX
Posted on Thursday February 21, 2019

If you are a shareholder who purchased Lexicon securities between March 11, 2016, and January 17, 2019, you have until April 1, 2019, to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at   To discuss this action, contact Robert S. Willoughby at or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980.

SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX) & Lead Plaintiff Deadline: April 1, 2019
Posted on Thursday February 21, 2019

NEW YORK, NY / ACCESSWIRE / February 21, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lexicon Pharmaceuticals, Inc. ("Lexicon" ...

Will Lexicon Pharmaceuticals (LXRX) Report Negative Q4 Earnings? What You Should Know
Posted on Thursday February 21, 2019

Lexicon (LXRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.